Just a few months after dumping its lead asset and cutting its workforce in half, Cargo Therapeutics is jettisoning even more ...
Cargo was founded by two highly acclaimed cell-therapy researchers. The company raised over $500 million to develop ...
Development of CRG-023 and allogeneic platform suspended; further reduction in force (RIF) of approximately 90% to preserve cash and maximize ...
Bay Area's CARGO Therapeutics Cuts Workforce by 90%, Halts Drug Development Amid Financial Struggles
CARGO Therapeutics slashes workforce, halts drug development after a failed trial, with plans for a potential reverse merger.
SAN CARLOS, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (Nasdaq: CRGX) today provided an update regarding its ongoing evaluation of strategic options following the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback